Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer
High Dose Chemotherapy With Stem Cell Rescue Followed By Consolidation Treatment in Patients With Metastatic Hormone-Refractory Prostate Cancer
Sponsor: University of Maryland, Baltimore
A PHASE2 clinical study on Prostate Cancer, this trial is completed. The trial is conducted by University of Maryland, Baltimore and has accumulated 8 data snapshots since 1998. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
Dec 2019 — Jan 2021 [monthly]
Completed PHASE2
-
Sep 2019 — Dec 2019 [monthly]
Completed PHASE2
▶ Show 3 earlier versions
-
Jun 2018 — Sep 2019 [monthly]
Completed PHASE2
-
Apr 2017 — Jun 2018 [monthly]
Completed PHASE2
Status: Unknown Status → Completed
-
Jan 2017 — Apr 2017 [monthly]
Unknown Status PHASE2
First recorded
Sep 1998
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Maryland, Baltimore
For direct contact, visit the study record on ClinicalTrials.gov .